[July 30, 2015] |
|
NovaBay Pharmaceuticals to Hold Second Quarter 2015 Conference Call on August 13
NovaBay®
Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical
company commercializing and developing topical non-antibiotic
antimicrobial products for the global eye care market, today announced
that it will report second quarter financial results after market close
on Thursday, August 13. Management will hold an investment community
conference call to discuss financial results and provide a company
update.
|
|
|
|
|
DATE:
|
|
|
|
Thursday, August 13, 2015
|
|
|
|
|
|
TIME:
|
|
|
|
4:30 p.m. Eastern time / 1:30 p.m. Pacific time
|
|
|
|
|
|
DIAL IN:
|
|
|
|
866-880-4999 from within the U.S.
|
|
|
|
|
702-495-1913 from outside the U.S.
|
|
|
|
|
Enter conference identification number 82923703
|
|
|
|
|
|
The live call also will be available at http://novabay.com/investors/events.
A replay of the call will be available beginning two hours after its
completion through 11:59 p.m. Eastern time August 27, 2015, by dialing
855-859-2056 from within the U.S. or 404-537-3406 from outside the U.S.
and entering the conference identification number 82923703. The call
will also be archived at http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics®
NovaBay Pharmaceuticals is a biopharmaceutical company focusing
commercializing and developing its non-antibiotic anti-infective
products to address the unmet therapeutic needs of the global, topical
anti-infective market with its two distinct product categories: the
NEUTROX™ Family of Products, including AVENOVA™
for the eye care market and NEUTROPHASE® for wound
care, and CELLERX® for the aesthetic
dermatology market, cleared by the FDA as a 510(k) medical device; and
its AGANOCIDE® compounds, led by AURICLOSENE™.
NovaBay is partnered in the U.S. and around the globe with: PBE, Inc.
(USA), IHT, Inc. (USA), Galderma (France), Virbac (France), China
Pioneer Pharma (China and Southeast Asia), Shin Poong Pharmaceuticals
(South Korea), Biopharm (North African and Middle East), Sarmedic Ltd
(Israel) and Alpha Pharma LLC (Ukraine).
NovaBay has received FDA-clearance of its intelli-Case,
a highly innovative, easy-to-use device for use with hydrogen peroxide
disinfection solutions with soft and Rigid Gas Permeable (RGP) contact
lenses.
Stay informed on NovaBay's progress: Download
our Mobile InvestorApp from the Apple
Store or Google
Play Like us on Facebook Follow
us on Twitter Connect
with NovaBay on LinkedIn Join
us on Google+ Visit
NovaBay's
Website
NovaBay Contacts
For NovaBay Avenova purchasing information, please contact: Email
us Call us: 1-800-890-0329 www.Avenova.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20150730006688/en/
[ Back To Mobile World Congress's Homepage ]
|